Bill Search

SB 2308
  • Introduced
    Mar 11, 2025
  • Passed Senate
    Apr 30, 2025
  • Passed House
    May 13, 2025
  • Signed into Law
SB 2308
Texas Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Last Action See all actions
House • May 31, 2025: Senate adopts conf. comm. report-reported
Latest Bill Text See all bill texts
Conference Committee Report*
House Calendar: Items Eligible for Consideration CONFERENCE COMMITTEE
Position: 7

Summary/Bill Text

Comments on SB 2308

Tweets

Whip Lists

Sponsors
Votes
May 12, 2025, House
CSSB 2308, as amended, was passed to third reading by (Record 2178): 141 Yeas, 2 Nays, 1 Present, not voting.
YES: 141
NO: 2
OTHER: 1
YES: 141

NO: 2

ABSENT: 6

NOT VOTING: 1

Sources
May 13, 2025, House
SB 2308 was passed by (Record 2324): 138 Yeas, 2 Nays, 2 Present, not voting.
YES: 138
NO: 2
OTHER: 2
YES: 138

NO: 2

ABSENT: 8

NOT VOTING: 2

Sources
Actions
  • May 31, 2025 | House
    • Senate adopts conf. comm. report-reported
  • May 31, 2025 | Senate
    • Senate adopts resolution to go outside bounds SR 703
    • Senate adopts conference committee report
    • Record vote
  • May 30, 2025 | House
    • Conf. Comm. Report distributed
  • May 30, 2025 | Senate
    • Conference committee report filed
  • May 21, 2025 | Senate
    • House grants request for conf comm-reported
    • House appoints conferees-reported
  • May 20, 2025 | House
    • House grants request for conference committee
    • House appoints conferees
  • May 15, 2025 | House
    • Senate refuses to concur-reported
    • Senate requests conference committee-reported
    • Senate appoints conferees-reported
  • May 15, 2025 | Senate
    • House amendment(s) laid before the Senate
    • Read
    • Senate refuses to concur
    • Senate requests conference committee
    • Senate appoints conferees
  • May 14, 2025 | Senate
    • House passage as amended reported
  • May 13, 2025 | House
    • Read 3rd time
    • Passed
    • Record vote RV#2324
    • Statement(s) of vote recorded in Journal
  • May 12, 2025 | House
    • Comte report filed with Committee Coordinator
    • Committee report distributed
    • Committee report sent to Calendars
    • Laid out in lieu of companion HB 3717
    • Read 2nd time
    • Amended 1-Harris
    • Passed to 3rd reading as amended
    • Record vote RV#2178
  • May 08, 2025 | House
    • Considered in formal meeting
    • Committee substitute considered in committee
    • Reported favorably as substituted
  • May 02, 2025 | House
    • Read first time
    • Referred to Public Health
  • May 01, 2025 | House
    • Received from the Senate
  • Apr 30, 2025 | Senate
    • Rules suspended-Regular order of business
    • Record vote
    • Read 2nd time & passed to engrossment
    • Record vote
    • Three day rule suspended
    • Record vote
    • Read 3rd time
    • Passed
    • Record vote
    • Reported engrossed
  • Apr 29, 2025 | Senate
    • Co-author authorized
    • Placed on intent calendar
  • Apr 28, 2025 | Senate
    • Reported favorably w/o amendments
    • Committee report printed and distributed
  • Apr 24, 2025 | Senate
    • Considered in public hearing
    • Vote taken in committee
  • Apr 23, 2025 | Senate
    • Scheduled for public hearing on . . . 04/23/2025
    • Considered in public hearing
    • Testimony taken in committee
    • Left pending in committee
  • Mar 25, 2025 | Senate
    • Read first time
    • Referred to Health & Human Services
  • Mar 11, 2025 | Senate
    • Received by the Secretary of the Senate
    • Filed
Bill Texts
Documents
Sources